Boston Partner Gabor Garai was quoted in a Boston Globe article published on August 17, 2013 titled “Some wonder how long Mass. IPO party can last.” The article discusses how long the Massachusetts IPO party can last despite the fact the biotechnology industry remains on track for its best year for initial public offerings since at least 2007. Mr. Garai was quoted saying, “There’s definitely lots of conversations with bankers and companies contemplating IPOs about the timing. Some people are accelerating their plans to go public because they don’t know how much longer the window is going to be open.”
People
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."